pharmaphorum November 30, 2022
The life sciences industry has reached an inflection point as 2023 approaches. Organisations must decide whether to embrace a digital-first mindset and implement innovative technology solutions — or stick with legacy methods.
Digital transformation involves adopting technologies to improve workflows, efficiency, and patient care. Organisations opting not to embark on a digital transformation journey risk developing data integrity issues, including poor documentation and data silos.
Companies determined to bring drugs to market more quickly and safely — and gain an edge on their competition next year (and beyond) — should leverage these three technology trends.
The value of the cloud
While slower than other industries to adopt it, many life sciences organisations have become more aware of cloud technology’s transformative...
Today's Sponsors
Today's Sponsor